IBOC vs LAZ
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
IBOC presents a stable but stagnant profile, characterized by a Piotroski F-Score of 4/9, indicating baseline financial health. While the stock is fundamentally undervalued relative to its Graham Number of $88.26 and analyst target of $87.00, it is hampered by negative year-over-year earnings growth (-7.60%) and a bearish technical trend score of 10/100. The company maintains strong profitability margins and a very sustainable dividend payout, but lacks the growth catalysts necessary for a bullish rating.
LAZ exhibits a stable but mediocre Piotroski F-Score of 4/9, while trading at a massive premium to its Graham Number ($21.31) and Intrinsic Value ($15.19). Despite strong ROE and consistent earnings beats, the company is facing a severe YoY earnings collapse of -43.30% and an unsustainable dividend payout ratio of 92.17%. Bearish insider activity and a 0/100 technical trend further signal a lack of confidence in the current price level of $48.51.
Compare Another Pair
Related Comparisons
IBOC vs LAZ: Head-to-Head Comparison
This page compares International Bancshares Corporation (IBOC) and Lazard, Inc. (LAZ) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.